Woven EndoBridge (WEB) Aneurysm Embolization System
Microvention, Inc. · Decision date Oct 27, 2026
What did the FDA decide?
The FDA record P170032/S024, dated 2026-10-27, describes a 30-Day Notice for a process change covering manufacturer, sterilizer, packager or supplier. The stated purpose is approval for an alternate supplier of the resin used in the WEB detachment controller housing. The changed item is therefore the resin source for that housing, not the device's clinical use or labeling.
This supplement sits under the original PMA identifier P170032 for a MicroVention intrasaccular flow disruption device in the OPR product code. It is not a new approval of the whole WEB Aneurysm Embolization System. The source does not state resin identity, qualification data, or any conclusion about safety or clinical effectiveness; the reported purpose is regulatory, and independent proof of those outcomes is absent.
FDA approval order statement
approval for an alternate supplier of the resin used in the WEB detachment controller housing
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Neurology
- Decision date
- Oct 27, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P170032/S024
- Regulatory pathway
- PMA supplement
- Applicant
- Microvention, Inc.
- Product code
- OPR
- Decision code
- OK30
- Decision date
- Oct 27, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Intrasaccular Flow Disruption Device.
- Applicant
- Microvention, Inc.
- Product code
- OPR
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P170032. Subsequent supplements may change the device or its indications.
FDA decision timeline
P170032 · Original PMA
Woven EndoBridge (WEB) Aneurysm Embolization System
P170032/S024 received
Application receipt date recorded by FDA.
P170032/S024 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P170032. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P170032
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Microvention, Inc. | PMA approval | Dec 31, 2018 | FDA |
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Microvention, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 35 Enterprise, Aliso Viejo, CA, 92656
Sources and methodology
- Original FDA record: P170032/S024
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records